Medicine and Dentistry
Cystic Fibrosis
100%
Sputum
70%
Immune Response
70%
Cystic Fibrosis Transmembrane Conductance Regulator
70%
Respiratory Tract Inflammation
70%
Serositis
70%
Experience
70%
Host
70%
Protein
58%
Therapeutic Procedure
33%
Silo-Filler's Disease
31%
Antibiotic Therapy
23%
Secretory Leukocyte Protease Inhibitor
23%
Disease Exacerbation
21%
Combination Therapy
20%
Lung
20%
Sodium Channel
17%
Enzyme Linked Immunosorbent Assay
11%
Cystatin
11%
Antiinfective Agent
11%
Cleft
11%
Measurement
11%
Liquid Chromatography-Mass Spectrometry
11%
Analysis
11%
Adult
11%
Proteinase Inhibitor
11%
Leukocyte Elastase
11%
Interleukin 8
11%
Interleukin 1
11%
Inhibitor Protein
11%
Host Resistance
9%
Infection
9%
Genotype
9%
Development
9%
Protein Defect
9%
Disease Management
9%
Body Mass Index
9%
Clinical Endpoint
9%
Immunocompetent Cell
9%
Pathogenic Organism
9%
Phagocyte
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
100%
Inflammation
79%
Host
70%
Biological Marker
70%
Respiratory Tract Inflammation
70%
Cystic Fibrosis Transmembrane Conductance Regulator
70%
Secretory Leukocyte Proteinase Inhibitor
70%
Diseases
23%
Lung Disease
20%
Sodium Channel
17%
Pathophysiology
14%
Life Expectancy
14%
Antibiotic Therapy
14%
Leukocyte Elastase
11%
Inhibitor Protein
11%
Disease Exacerbation
9%
Protein Defect
9%
Infection
9%
Organisms
9%
Cathepsin G
5%
Immunology and Microbiology
Conductance
70%
Inflammation Response
70%
Immune Response
70%
Sputum
70%
Lung
40%
Inflammation
29%
Host Immune Response
23%
White Blood Cell
23%
Neutrophil Granulocyte
11%
Liquid Chromatography Mass Spectrometry
11%
Development
9%
Organisms
9%
Genotype
9%
Light
9%
Host Resistance
9%
Body Mass
9%
Immunocompetent Cell
9%
Phagocyte
9%
Molecule
9%
